Published in Medical Device Business Week, February 9th, 2005
"Ten percent of the U.S. workforce abuses drugs which costs employers more than $110B every year," shares Peter Phildius, chairman and CEO of Avitar.
"Companies that lack corporate drug testing programs suffer repercussions in cost and safety including: higher employee turnover and absenteeism,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.